Masahide Oki

National Hospital Organization Nagoya Medical Center

SCHOLARLY PAPERS

4

DOWNLOADS

97

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

A Phase II Study (WJOG12819L) to Assess the Efficacy of Osimertinib in Patients with EGFR Mutation-Positive NSCLC in Whom Systemic Disease (T790M-Negative) Progressed after Treatment with First- Or Second-Generation EGFR TKIS and Platinum-Based Chemotherapy

Number of pages: 19 Posted: 04 Jan 2023
Kindai University, Yamaguchi University, Sendai Kousei Hospital, National Cancer Center Hospital East, Saitama Cancer Center, Kanagawa Cancer Center, Juntendo University - Juntendo University Hospital, Niigata Cancer Center Hospital, Shizuoka Cancer Center, National Hospital Organization Nagoya Medical Center, Kobe University, Wakayama Medical University, Kindai University, Hiroshima University - Hiroshima University Hospital, Ehime University Graduate School of Medicine, Kyushu University - Kyushu University Hospital, Kurume University - Department of Internal Medicine, Japan Lung Cancer Alliance, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology and Kindai University
Downloads 32 (1,024,170)

Abstract:

Loading...

lung cancer, EGFR, T790-negative, Osimertinib, Patient-initiated clinical trial

2.

Removal of a Foreign Body by Rigid Bronchoscope after Virtual Reality-Aided Presurgical Planning: A Case Report

Number of pages: 9 Posted: 05 Apr 2022
National Hospital Organization (NHO) - Nagoya Medical Center, affiliation not provided to SSRN, Colorado State University, Fort Collins, Colorado State University, Fort Collins, affiliation not provided to SSRN, affiliation not provided to SSRN and National Hospital Organization Nagoya Medical Center
Downloads 32 (1,024,170)

Abstract:

Loading...

airway foreign body, orthodontic appliance, rigid bronchoscopy, Insulation-Tipped diathermic knife, virtual reality

3.

A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients with Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring Met Exon 14 Alterations Who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)

Number of pages: 11 Posted: 29 Aug 2024
Kindai University, Nara Medical University, Kyushu University - Kyushu University Hospital, Sendai Kousei Hospital - Department of Pulmonary Medicine, Juntendo University, affiliation not provided to SSRN, Niigata Cancer Center Hospital, National Hospital Organization Nagoya Medical Center, Kindai University, Hiroshima University - Hiroshima University Hospital, Ehime University and Yamaguchi University
Downloads 20 (1,167,001)

Abstract:

Loading...

Lung cancer, MET, acquired resistance, cabozantinib, clinical trial

4.

Mechanisms of Resistance and Correlation between Pre-Treatment Co-Alterations and Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer

Number of pages: 34 Posted: 12 Jun 2024
Kinki-chuo Chest Medical Center, Wakayama Medical University, Shikoku Cancer Centre, Kinki-chuo Chest Medical Center, Kinki-chuo Chest Medical Center, Asahikawa Medical University, National Hospital Organization Himeji Medical Center, National Hospital Organization Kochi Hospital, National Hospital Organization (NHO) - Mito Medical Center, National Hospital Organization Ureshino Medical Center, National Hospital Organization Nagoya Medical Center, National Hospital Organization (NHO) - Osaka Toneyama Medical Center, National Hospital Organization Shibukawa Medical Center, Nagoya University - Department of Advanced Medicine, National Hospital Organization Kyushu Medical Center, National Hospital Organization (NHO) - Department of Respiratory Diseases and Wakayama Medical University
Downloads 13 (1,261,818)

Abstract:

Loading...

osimertinib, non-small cell lung cancer, epidermal growth factor receptor, resistance mechanism, circulating tumour DNA